GBM Resources (ASX:GBZ) has raised US$1.0 million via a placement
GBM Resources has completed a fundraising. Funds raised will be used to accelerate exploration and drilling on the highly prospective Drummond Basin, specifically at Twin Hills and Yandan, over the next 12 months.
GBM Resources is a mineral exploration and development company focused on the discovery of world-class gold and copper deposits in Eastern Australia. The company has a high caliber project portfolio, hosting district-scale mineral systems, located in several premier metallogenic terrains, including the Drummond Basin, Mt Morgan district and the Mt Isa Inlier in Queensland, and the Malmsbury project in the prolific Victorian goldfields.
Oaklins’ team in Australia acted as lead manager on a AU$1.5m (US$1 million) share placement for GBM Resources that was strongly supported by two institutional cornerstone investors. This is the fifth capital raise where Oaklins has advised GBM Resources, and we look forward to further strengthening our relationship as they continue to progress exploration and drilling activities.


Talk to the deal team
Related deals
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moredoValue has finalized a rights issue
doValue has successfully completed a rights issue. The capital increase was implemented to finance doValue’s acquisition of Gardant.
Learn more